Annual Net Income
-$5.69 M
+$15.41 M+73.02%
December 31, 2023
Summary
- As of February 8, 2025, FRTX annual net profit is -$5.69 million, with the most recent change of +$15.41 million (+73.02%) on December 31, 2023.
- During the last 3 years, FRTX annual net income has risen by +$15.22 million (+72.77%).
- FRTX annual net income is now -306.71% below its all-time high of -$1.40 million, reached on December 1, 1993.
Performance
FRTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$1.24 M
-$3.34 M-158.84%
December 31, 2023
Summary
- As of February 8, 2025, FRTX quarterly net profit is -$1.24 million, with the most recent change of -$3.34 million (-158.84%) on December 31, 2023.
- Over the past year, FRTX quarterly net income has dropped by -$3.34 million (-158.84%).
- FRTX quarterly net income is now -107.53% below its all-time high of $16.43 million, reached on September 1, 2011.
Performance
FRTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$5.69 M
+$3.29 M+36.61%
December 31, 2023
Summary
- As of February 8, 2025, FRTX TTM net profit is -$5.69 million, with the most recent change of +$3.29 million (+36.61%) on December 31, 2023.
- Over the past year, FRTX TTM net income has increased by +$3.29 million (+36.61%).
- FRTX TTM net income is now -359.64% below its all-time high of $2.19 million, reached on June 1, 2012.
Performance
FRTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
FRTX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +73.0% | -158.8% | +36.6% |
| 3 y3 years | +72.8% | -158.8% | +36.6% |
| 5 y5 years | +65.0% | -158.8% | +36.6% |
FRTX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.6% | -158.8% | +86.8% | at high | +85.7% |
| 5 y | 5-year | at high | +85.6% | -158.8% | +90.7% | at high | +86.0% |
| alltime | all time | -306.7% | +85.6% | -107.5% | +90.7% | -359.6% | +86.0% |
Fresh Tracks Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$5.69 M(-73.0%) | -$1.24 M(-158.8%) | -$5.69 M(-36.6%) |
| Sep 2023 | - | $2.10 M(-192.1%) | -$8.98 M(-47.5%) |
| Jun 2023 | - | -$2.28 M(-46.6%) | -$17.11 M(+7.1%) |
| Mar 2023 | - | -$4.28 M(-5.5%) | -$15.97 M(-24.3%) |
| Dec 2022 | -$21.10 M(-46.5%) | -$4.53 M(-24.8%) | -$21.10 M(-6.8%) |
| Sep 2022 | - | -$6.02 M(+424.7%) | -$22.64 M(-24.2%) |
| Jun 2022 | - | -$1.15 M(-87.8%) | -$29.88 M(-25.1%) |
| Mar 2022 | - | -$9.41 M(+55.1%) | -$39.88 M(+1.0%) |
| Dec 2021 | -$39.47 M(+88.8%) | - | - |
| Dec 2021 | - | -$6.07 M(-54.2%) | -$39.47 M(-3.2%) |
| Sep 2021 | - | -$13.25 M(+18.9%) | -$40.77 M(+28.0%) |
| Jun 2021 | - | -$11.15 M(+23.8%) | -$31.84 M(+23.4%) |
| Mar 2021 | - | -$9.01 M(+22.3%) | -$25.82 M(+23.4%) |
| Dec 2020 | -$20.91 M(-12.4%) | -$7.37 M(+70.2%) | -$20.91 M(-14.3%) |
| Sep 2020 | - | -$4.33 M(-15.5%) | -$24.41 M(-1.8%) |
| Jun 2020 | - | -$5.12 M(+24.8%) | -$24.86 M(+12.1%) |
| Mar 2020 | - | -$4.10 M(-62.2%) | -$22.18 M(-2.1%) |
| Dec 2019 | -$23.88 M(+46.9%) | -$10.86 M(+127.2%) | -$22.65 M(+47.1%) |
| Sep 2019 | - | -$4.78 M(+96.7%) | -$15.40 M(+27.0%) |
| Jun 2019 | - | -$2.43 M(-46.9%) | -$12.13 M(-16.7%) |
| Mar 2019 | - | -$4.58 M(+27.0%) | -$14.56 M(-10.4%) |
| Dec 2018 | -$16.25 M(+25.4%) | -$3.60 M(+138.6%) | -$16.25 M(-0.8%) |
| Sep 2018 | - | -$1.51 M(-69.0%) | -$16.38 M(-8.8%) |
| Jun 2018 | - | -$4.87 M(-22.4%) | -$17.95 M(+9.4%) |
| Mar 2018 | - | -$6.27 M(+68.2%) | -$16.41 M(+26.6%) |
| Dec 2017 | -$12.96 M(+44.4%) | -$3.73 M(+20.7%) | -$12.96 M(+8.0%) |
| Sep 2017 | - | -$3.09 M(-7.0%) | -$12.00 M(+4.9%) |
| Jun 2017 | - | -$3.32 M(+17.6%) | -$11.44 M(+22.0%) |
| Mar 2017 | - | -$2.82 M(+1.9%) | -$9.37 M(+4.5%) |
| Dec 2016 | -$8.97 M(-2.9%) | -$2.77 M(+9.9%) | -$8.97 M(+4.9%) |
| Sep 2016 | - | -$2.52 M(+101.0%) | -$8.56 M(+35.1%) |
| Jun 2016 | - | -$1.25 M(-48.2%) | -$6.33 M(-19.2%) |
| Mar 2016 | - | -$2.42 M(+2.9%) | -$7.84 M(-15.1%) |
| Dec 2015 | -$9.24 M(-44.0%) | -$2.35 M(+685.0%) | -$9.24 M(-19.8%) |
| Sep 2015 | - | -$300.00 K(-89.1%) | -$11.52 M(-26.1%) |
| Jun 2015 | - | -$2.76 M(-27.7%) | -$15.58 M(-7.6%) |
| Mar 2015 | - | -$3.82 M(-17.5%) | -$16.86 M(+2.2%) |
| Dec 2014 | -$16.49 M(-47.2%) | -$4.63 M(+6.2%) | -$16.49 M(+17.4%) |
| Sep 2014 | - | -$4.36 M(+8.0%) | -$14.05 M(-28.2%) |
| Jun 2014 | - | -$4.04 M(+16.9%) | -$19.57 M(-23.0%) |
| Mar 2014 | - | -$3.46 M(+57.6%) | -$25.41 M(-18.7%) |
| Dec 2013 | -$31.24 M(+36.4%) | -$2.19 M(-77.8%) | -$31.24 M(-14.6%) |
| Sep 2013 | - | -$9.88 M(+0.0%) | -$36.59 M(+6.3%) |
| Jun 2013 | - | -$9.88 M(+6.5%) | -$34.44 M(+6.2%) |
| Mar 2013 | - | -$9.28 M(+23.0%) | -$32.42 M(+41.6%) |
| Dec 2012 | -$22.90 M(+214.4%) | -$7.55 M(-2.3%) | -$22.90 M(+4.3%) |
| Sep 2012 | - | -$7.73 M(-1.8%) | -$21.96 M(-1101.6%) |
| Jun 2012 | - | -$7.87 M(-3324.6%) | $2.19 M(+32.5%) |
| Mar 2012 | - | $244.00 K(-103.7%) | $1.66 M(-122.7%) |
| Dec 2011 | -$7.28 M(-76.0%) | -$6.61 M(-140.3%) | -$7.28 M(-2.0%) |
| Sep 2011 | - | $16.43 M(-295.5%) | -$7.43 M(-75.7%) |
| Jun 2011 | - | -$8.41 M(-3.3%) | -$30.63 M(+0.1%) |
| Mar 2011 | - | -$8.69 M(+28.6%) | -$30.60 M(+0.7%) |
| Dec 2010 | -$30.39 M(+6.4%) | -$6.76 M(-0.1%) | -$30.39 M(-1.8%) |
| Sep 2010 | - | -$6.77 M(-19.2%) | -$30.93 M(-0.7%) |
| Jun 2010 | - | -$8.38 M(-1.2%) | -$31.15 M(+8.2%) |
| Mar 2010 | - | -$8.48 M(+16.0%) | -$28.79 M(+0.8%) |
| Dec 2009 | -$28.56 M(-22.6%) | -$7.31 M(+4.6%) | -$28.56 M(-5.7%) |
| Sep 2009 | - | -$6.99 M(+16.0%) | -$30.27 M(-8.6%) |
| Jun 2009 | - | -$6.02 M(-27.0%) | -$33.11 M(-6.9%) |
| Mar 2009 | - | -$8.24 M(-8.6%) | -$35.58 M(-3.6%) |
| Dec 2008 | -$36.90 M(+2.8%) | -$9.02 M(-8.2%) | -$36.90 M(+0.4%) |
| Sep 2008 | - | -$9.82 M(+15.8%) | -$36.73 M(+1.6%) |
| Jun 2008 | - | -$8.48 M(-11.3%) | -$36.15 M(+0.8%) |
| Mar 2008 | - | -$9.56 M(+7.9%) | -$35.86 M(-0.1%) |
| Dec 2007 | -$35.89 M | -$8.86 M(-4.1%) | -$35.89 M(+2.7%) |
| Sep 2007 | - | -$9.24 M(+12.7%) | -$34.95 M(+5.2%) |
| Jun 2007 | - | -$8.20 M(-14.6%) | -$33.23 M(+17.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$9.60 M(+21.1%) | -$28.27 M(+22.1%) |
| Dec 2006 | -$23.15 M(-5.0%) | -$7.92 M(+5.5%) | -$23.15 M(+10.8%) |
| Sep 2006 | - | -$7.51 M(+131.5%) | -$20.89 M(+7.1%) |
| Jun 2006 | - | -$3.24 M(-27.5%) | -$19.51 M(-8.2%) |
| Mar 2006 | - | -$4.47 M(-21.1%) | -$21.25 M(-12.7%) |
| Dec 2005 | -$24.36 M(+2.6%) | -$5.67 M(-7.6%) | -$24.36 M(+5.2%) |
| Sep 2005 | - | -$6.13 M(+23.1%) | -$23.16 M(+5.7%) |
| Jun 2005 | - | -$4.98 M(-34.3%) | -$21.90 M(-1.5%) |
| Mar 2005 | - | -$7.58 M(+69.6%) | -$22.24 M(-6.3%) |
| Dec 2004 | -$23.73 M(-2.9%) | -$4.47 M(-8.4%) | -$23.73 M(-9.5%) |
| Sep 2004 | - | -$4.88 M(-8.3%) | -$26.21 M(+5.3%) |
| Jun 2004 | - | -$5.32 M(-41.4%) | -$24.89 M(-6.1%) |
| Mar 2004 | - | -$9.07 M(+30.7%) | -$26.50 M(+8.4%) |
| Dec 2003 | -$24.45 M(-12.5%) | -$6.95 M(+95.3%) | -$24.45 M(-2.1%) |
| Sep 2003 | - | -$3.56 M(-48.6%) | -$24.98 M(-21.0%) |
| Jun 2003 | - | -$6.92 M(-1.5%) | -$31.64 M(+6.4%) |
| Mar 2003 | - | -$7.02 M(-6.0%) | -$29.73 M(+6.4%) |
| Dec 2002 | -$27.93 M(+202.3%) | -$7.47 M(-26.9%) | -$27.93 M(+27.6%) |
| Sep 2002 | - | -$10.22 M(+103.5%) | -$21.89 M(+53.8%) |
| Jun 2002 | - | -$5.02 M(-3.9%) | -$14.23 M(+14.0%) |
| Mar 2002 | - | -$5.22 M(+265.4%) | -$12.49 M(+35.1%) |
| Dec 2001 | -$9.24 M(+8.5%) | -$1.43 M(-44.1%) | -$9.24 M(-18.1%) |
| Sep 2001 | - | -$2.56 M(-22.0%) | -$11.28 M(+8.3%) |
| Jun 2001 | - | -$3.28 M(+65.6%) | -$10.41 M(+34.0%) |
| Mar 2001 | - | -$1.98 M(-42.9%) | -$7.77 M(-10.7%) |
| Dec 2000 | -$8.52 M(+23.4%) | -$3.47 M(+105.4%) | -$8.70 M(+60.1%) |
| Sep 2000 | - | -$1.69 M(+165.7%) | -$5.43 M(-17.0%) |
| Jun 2000 | - | -$635.10 K(-78.2%) | -$6.55 M(-27.4%) |
| Mar 2000 | - | -$2.91 M(+1355.3%) | -$9.01 M(+30.6%) |
| Dec 1999 | -$6.90 M(-8.0%) | -$200.00 K(-92.9%) | -$6.90 M(-21.6%) |
| Sep 1999 | - | -$2.80 M(-9.7%) | -$8.80 M(+12.8%) |
| Jun 1999 | - | -$3.10 M(+287.5%) | -$7.80 M(+2.6%) |
| Mar 1999 | - | -$800.00 K(-61.9%) | -$7.60 M(+1.3%) |
| Dec 1998 | -$7.50 M(+33.9%) | -$2.10 M(+16.7%) | -$7.50 M(+15.4%) |
| Sep 1998 | - | -$1.80 M(-37.9%) | -$6.50 M(+32.7%) |
| Jun 1998 | - | -$2.90 M(+314.3%) | -$4.90 M(+14.0%) |
| Mar 1998 | - | -$700.00 K(-36.4%) | -$4.30 M(-23.2%) |
| Dec 1997 | -$5.60 M(+9.8%) | -$1.10 M(+450.0%) | -$5.60 M(-5.1%) |
| Sep 1997 | - | -$200.00 K(-91.3%) | -$5.90 M(-24.4%) |
| Jun 1997 | - | -$2.30 M(+15.0%) | -$7.80 M(+52.9%) |
| Mar 1997 | - | -$2.00 M(+42.9%) | -$5.10 M(+2.0%) |
| Dec 1996 | -$5.10 M(+27.5%) | -$1.40 M(-33.3%) | -$5.00 M(0.0%) |
| Sep 1996 | - | -$2.10 M(-625.0%) | -$5.00 M(+25.0%) |
| Jun 1996 | - | $400.00 K(-121.1%) | -$4.00 M(-9.1%) |
| Mar 1996 | - | -$1.90 M(+35.7%) | -$4.40 M(+10.0%) |
| Dec 1995 | -$4.00 M(-9.1%) | -$1.40 M(+27.3%) | -$4.00 M(-13.0%) |
| Sep 1995 | - | -$1.10 M(-26.7%) | -$4.60 M(0.0%) |
| Mar 1995 | - | -$1.50 M(-25.0%) | -$4.60 M(+4.5%) |
| Dec 1994 | -$4.40 M(+214.3%) | -$2.00 M(+185.7%) | -$4.40 M(+25.7%) |
| Sep 1994 | - | -$700.00 K(+75.0%) | -$3.50 M(-10.3%) |
| Jun 1994 | - | -$400.00 K(-69.2%) | -$3.90 M(-17.0%) |
| Mar 1994 | - | -$1.30 M(+18.2%) | -$4.70 M(+213.3%) |
| Dec 1993 | -$1.40 M(-30.0%) | -$1.10 M(0.0%) | -$1.50 M(+36.4%) |
| Sep 1993 | - | -$1.10 M(-8.3%) | -$1.10 M(+120.0%) |
| Jun 1993 | - | -$1.20 M(-163.2%) | -$500.00 K(-266.7%) |
| Mar 1993 | - | $1.90 M(-371.4%) | $300.00 K(-115.0%) |
| Dec 1992 | -$2.00 M(-13.0%) | -$700.00 K(+40.0%) | -$2.00 M(+5.3%) |
| Sep 1992 | - | -$500.00 K(+25.0%) | -$1.90 M(-5.0%) |
| Jun 1992 | - | -$400.00 K(0.0%) | -$2.00 M(-9.1%) |
| Mar 1992 | - | -$400.00 K(-33.3%) | -$2.20 M(-4.3%) |
| Dec 1991 | -$2.30 M(+35.3%) | -$600.00 K(0.0%) | -$2.30 M(+4.5%) |
| Sep 1991 | - | -$600.00 K(0.0%) | -$2.20 M(+10.0%) |
| Jun 1991 | - | -$600.00 K(+20.0%) | -$2.00 M(+11.1%) |
| Mar 1991 | - | -$500.00 K(0.0%) | -$1.80 M(+5.9%) |
| Dec 1990 | -$1.70 M | -$500.00 K(+25.0%) | -$1.70 M(+41.7%) |
| Sep 1990 | - | -$400.00 K(0.0%) | -$1.20 M(+50.0%) |
| Jun 1990 | - | -$400.00 K(0.0%) | -$800.00 K(+100.0%) |
| Mar 1990 | - | -$400.00 K | -$400.00 K |
FAQ
- What is Fresh Tracks Therapeutics annual net profit?
- What is the all time high annual net income for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics annual net income year-on-year change?
- What is Fresh Tracks Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly net income year-on-year change?
- What is Fresh Tracks Therapeutics TTM net profit?
- What is the all time high TTM net income for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics TTM net income year-on-year change?
What is Fresh Tracks Therapeutics annual net profit?
The current annual net income of FRTX is -$5.69 M
What is the all time high annual net income for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual net profit is -$1.40 M
What is Fresh Tracks Therapeutics annual net income year-on-year change?
Over the past year, FRTX annual net profit has changed by +$15.41 M (+73.02%)
What is Fresh Tracks Therapeutics quarterly net profit?
The current quarterly net income of FRTX is -$1.24 M
What is the all time high quarterly net income for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly net profit is $16.43 M
What is Fresh Tracks Therapeutics quarterly net income year-on-year change?
Over the past year, FRTX quarterly net profit has changed by -$3.34 M (-158.84%)
What is Fresh Tracks Therapeutics TTM net profit?
The current TTM net income of FRTX is -$5.69 M
What is the all time high TTM net income for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high TTM net profit is $2.19 M
What is Fresh Tracks Therapeutics TTM net income year-on-year change?
Over the past year, FRTX TTM net profit has changed by +$3.29 M (+36.61%)